Schauer A, Korabiowska M, Kellner S, Schumacher M, Sauer R, Bojar H, Rauschecker H
Department of Pathology, University of Göttingen, Germany.
Anticancer Res. 1998 May-Jun;18(3C):2139-44.
As recurrence rates in breast cancer depend significantly on degree of malignancy (6-9) and mitotic rates as part of the grading system are difficult to assess in exact manner, we widened the grading system by evaluation of the proliferative compartment to get more information about proliferation activity as an important factor for tumor-progression (15, 16). This additional analysis can be used as a control factor for the correctness of the evaluation of mitotic activity. We practice this procedure at present as a "working formulation". New antibodies are in preparation which allow to exclude the highly variable G1-Phase. Further precision and control of degree of malignancy can be achieved by photometric analysis of S-Phase, 5c exceeding rate and state of ploidy according to Auer scheme.
由于乳腺癌的复发率在很大程度上取决于恶性程度(6 - 9),并且作为分级系统一部分的有丝分裂率难以精确评估,我们通过评估增殖区室来拓宽分级系统,以获取更多关于增殖活性的信息,而增殖活性是肿瘤进展的一个重要因素(15, 16)。这种额外的分析可作为有丝分裂活性评估正确性的控制因素。我们目前将此程序作为一种“工作方案”来实施。正在制备新的抗体,这些抗体能够排除高度可变的G1期。根据奥尔方案,通过对S期、5c超过率和倍体状态进行光度分析,可以进一步提高恶性程度评估的精确性和可控性。